Pharma News

A major breakthrough for adults living with rare inherited blood disorders, the U.S. Food and Drug Administration (FDA) has officially approved Agios Pharmaceuticals’ oral drug AQVESME™ (mitapivat) for the treatment of anemia in both alpha- and beta-thalassemia, regardless of whether patients require regular blood transfusions or not.

Biofabri and Bharat Biotech International Limited have signed a technology transfer agreement aimed at improving worldwide access to the promising TB vaccine candidate, MTBVAC.

The World Health Organization (WHO) has come out with a new global analysis that shows there are major equity gaps in human genomics research, especially between rich and poorer countries.

The study – the largest double-blind placebo-controlled clinical trial ever completed in DCP – evaluated the efficacy of 14 weeks of treatment with valbenazine compared with placebo in pediatric and adult participants who have dyskinesia due to cerebral palsy with choreiform movements. Adverse events were generally consistent with the established safety profile for valbenazine.

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved the Wegovy® pill (once-daily oral semaglutide 25 mg) to reduce excess body weight and maintain weight reduction long term and to reduce the risk of major adverse cardiovascular events.

Pfizer India and Cipla Limited announced a partnership where Cipla will exclusively market and distribute four brands of Pfizer in India.

Total 36 different medical devices are manufactured under Production Linked Incentive (PLI) Scheme for promoting domestic manufacturing of medical devices in India. These medical devices belong to different portfolios such as Imaging & Diagnostics, Critical Care & Emergency, Interventional CardioVascular, Renal Care Devices, Orthopaedic Implants, Oncology and specialist divisions.

Target set to increase the number of Jan Aushadhi Kendras to 25,000 by March 2027.